Clinical Trials Logo

Clinical Trial Summary

The purpose of the type II diabetes (T2D) screening study is to improve diabetes care in minority communities by identifying undiagnosed and uncontrolled T2D patients, as well as help patients without a regular primary care physician (PCP) find one within their community. These goals will be achieved first through a glucose measurement. Individuals with a high glucose measurement will be confirmed with a rapid hemoglobin A1c (HgA1c) test. The HgA1c test will tell us about the patients average blood sugar over the past 3 months, which will allow us to immediately diagnose new and uncontrolled type II diabetics. All participants will fill out a survey on healthcare seeking behaviors before glucose testing. All patients who enter the study will receive education on T2D and the value of regularly visiting their PCP, and will be provided a list of PCP currently accepting new patients within a 3 mile radius. Follow-up visits at 4 and 8 months will help us determine the success this community based screening.

The investigators hypothesis is that community based screening designed with adequate education and follow-up, and performed by qualified medical professionals will improve diabetes care in minority communities as assessed through hemoglobin A1c levels over 8 months, and in the change in the number patients who visit/obtain their PCP within the study period.


Clinical Trial Description

n/a


Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01591525
Study type Observational
Source Ethnicity and Disease Community Empowerment Center
Contact Kelly Lamb, MA
Phone 617-947-9095
Email lambkellyann@gmail.com
Status Not yet recruiting
Phase N/A
Start date June 2012
Completion date January 2013

See also
  Status Clinical Trial Phase
Recruiting NCT03743779 - Mastering Diabetes Pilot Study
Recruiting NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Recruiting NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) Phase 3
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Not yet recruiting NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Active, not recruiting NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT00339482 - Prospective Studies of the Natural History of Diabetes Mellitus and Its Complications in the Gila River Indian Community
Recruiting NCT03285308 - A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Phase 3
Recruiting NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Enrolling by invitation NCT03660631 - Dissemination of the Cardiovascular Risk Service N/A
Completed NCT03359629 - Spectrophon LTD Glucometry Monitor Accuracy N/A
Completed NCT03238898 - Botulinum Toxin for Cramps in Diabetic Neuropathy Phase 2
Recruiting NCT03112343 - Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment N/A
Completed NCT00382564 - Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease N/A
Recruiting NCT03682640 - Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes Phase 2
Not yet recruiting NCT03462420 - Physiotherapy Program for Managing Adhesive Capsulitis in Patients With Diabetes N/A
Not yet recruiting NCT03607617 - ASCEND: ApproacheS to CHC ImplEmeNtation of SDH Data Collection and Action
Not yet recruiting NCT02042339 - Hyperbaric Oxygenation in Diabetic Ulcer Phase 3